Review
Open access
Aug 2026
In vivo CAR T cells on the highway: a roadmap for the next decade
Although still in its infancy, in vivo genetic engineering shows promise for CAR T cell therapy in a wide range of cancer patients and has the potential to reprogram patients’ immunity in autoimmunity, chronic infections, and regenerative medicine.
Markus Barden, D. Harrer, Hinrich Abken
· Expert Opinion on Biological... · 0 citations